Would you have Diarrhea when you have Multiple Sclerosis?


Diarrhea is found among people with Multiple sclerosis, especially for people who are female, 50-59 old, take medication Tecfidera and have Depression. We study 11,165 people who have Diarrhea and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Multiple Sclerosis

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Avonex, Tysabri, Rebif, Baclofen (latest reports from 409,739 Multiple sclerosis patients)


Diarrhea has been reported by people with breathing difficulty, fever, rashes, drug ineffective, weakness (latest reports from 253,439 Diarrhea patients).

On Sep, 16, 2016

11,165 people who have Multiple Sclerosis and Diarrhea are studied.

Number of reports submitted per year:

Would you have Diarrhea when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experience Diarrhea *:

  • female: 82.62 %
  • male: 17.38 %

Age of people who have Multiple Sclerosis and experience Diarrhea *:

  • 0-1: 0.05 %
  • 2-9: 0.01 %
  • 10-19: 0.48 %
  • 20-29: 4.01 %
  • 30-39: 14.01 %
  • 40-49: 27.81 %
  • 50-59: 32.25 %
  • 60+: 21.37 %

Severity if Multiple Sclerosis and experience Diarrhea *:

  • least: 0.0 %
  • moderate: 75 %
  • severe: 25 %
  • most severe: 0.0 %

Top co-existing conditions for these people *:

  • Depression (206 people, 1.85%)
  • Pain (179 people, 1.60%)
  • Gait Disturbance (145 people, 1.30%)
  • Hypertension (142 people, 1.27%)
  • Relapsing-Remitting Multiple Sclerosis (104 people, 0.93%)
  • Muscle Spasms (84 people, 0.75%)
  • Anxiety (80 people, 0.72%)
  • Gastrooesophageal Reflux Disease (79 people, 0.71%)
  • Sleep Disorder (67 people, 0.60%)
  • Prophylaxis (52 people, 0.47%)

Most common drugs for these people *:

  • Tecfidera (4,219 people, 37.79%)
  • Tysabri (2,230 people, 19.97%)
  • Avonex (2,140 people, 19.17%)
  • Aubagio (1,644 people, 14.72%)
  • Gilenya (722 people, 6.47%)
  • Rebif (529 people, 4.74%)
  • Ampyra (474 people, 4.25%)
  • Vitamin D (382 people, 3.42%)
  • Copaxone (314 people, 2.81%)
  • Baclofen (298 people, 2.67%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Diarrhea and Multiple sclerosis?

Browse all symptoms of Multiple sclerosis

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Diarrhea


Other conditions that could case Diarrhea


Related studies

Can you answer these questions?

More questions for: Multiple sclerosis, Diarrhea

You may be interested in these reviews

More reviews for: Multiple sclerosis, Diarrhea

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.